XML 134 R93.htm IDEA: XBRL DOCUMENT v3.22.0.1

Financial Instruments and Risk Management - Marketable securities (Details)	Oct. 31, 2021 CAD ($)	Nov. 18, 2020 CAD ($) EquityInstruments
Pathway Health Corp
Disclosure of nature and extent of risks arising from financial instruments [line items]
Marketable securities		$ 225,000
Meta Growth Corp
Disclosure of nature and extent of risks arising from financial instruments [line items]
Number of units of equity issued as part of consideration for business combination | EquityInstruments		196,063,610
Marketable securities		$ 635,000
Meta Growth Corp | THC Global Group Limited
Disclosure of nature and extent of risks arising from financial instruments [line items]
Number of units of equity issued as part of consideration for business combination		2,996,612
Marketable securities		$ 360,000
Meta Growth Corp | Pathway Health Corp
Disclosure of nature and extent of risks arising from financial instruments [line items]
Number of units of equity issued as part of consideration for business combination		400,000
Marketable securities		$ 200,000
Fair value of marketable securities	$ 96,000

X

- Definition

The fair value amount marketable securities.

+ References

No definition available.

+ Details

Name:	hiti_FairValueOfMarketableSecurities
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The amount recognised as of the acquisition date for marketable securities acquired in a business combination.

+ References

No definition available.

+ Details

Name:	hiti_MarketableSecuritiesRecognisedAsOfAcquisitionDate
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2021-01-01
-Paragraph B64
-Subparagraph f
-Clause iv
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

X

- Details

Name:	ifrs-full_CounterpartiesAxis=hiti_PathwayHealthCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_BusinessCombinationsAxis=hiti_MetaGrowthCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CounterpartiesAxis=hiti_THCGlobalGroupLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: